Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges

被引：24
|
作者：
Vitorino, Carla [1 ,2 ,3 ]
Silva, Soraia [1 ,2 ]
Bicker, Joana [1 ,2 ]
Falcao, Amilcar [1 ,2 ,4 ]
Fortuna, Ana [1 ,2 ,4 ]
机构：
[1] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[2] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal
[3] Univ Coimbra, Coimbra Chem Ctr, Dept Chem, Coimbra, Portugal
[4] Univ Coimbra, Coimbra Inst Biomed Imaging & Translat Res, CIBIT ICNAS, Coimbra, Portugal
来源：
DRUG DISCOVERY TODAY | 2019年 / 24卷 / 09期
关键词：
DRUG-DELIVERY; INTRANASAL INSULIN; NEUROPEPTIDE-Y; DOUBLE-BLIND; ANXIETY; SYSTEM; NANOPARTICLES; ESKETAMINE; DISORDERS; COGNITION;
D O I：
10.1016/j.drudis.2019.06.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Why is nose-to-brain delivery considered to be a strategy that directly allows the access of antidepressants to the brain? In which circumstances can the intranasal pathway be applicable? Are there any requirements to follow? What triggers the antidepressant market? Which constraints are imposed during discovery programs? What opportunities can arise and what is their current status of development? Are they already translated into clinical practice? Which challenges are expected from recent development strategies? This review aims at providing a critical appraisal of nose-to-brain delivery of antidepressants, framed within a comprehensive analysis of drivers, restraints, opportunities and challenges.
引用
收藏
页码：1911 / 1923
页数：13
相关论文
共 50 条
  • [31] Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles
    Nigam, Kuldeep
    Kaur, Atinderpal
    Tyagi, Amit
    Nematullah, Md
    Khan, Farah
    Gabrani, Reema
    Dang, Shweta
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2019, 9 (05) : 879 - 890
  • [32] Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
    Musumeci, Teresa
    Bonaccorso, Angela
    Puglisi, Giovanni
    PHARMACEUTICS, 2019, 11 (03)
  • [33] Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
    Bourganis, Vassilis
    Kammona, Olga
    Alexopoulos, Aleck
    Kiparissides, Costas
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 128 : 337 - 362
  • [34] Microemulsion-Based Media in Nose-to-Brain Drug Delivery
    Froelich, Anna
    Osmalek, Tomasz
    Jadach, Barbara
    Puri, Vinam
    Michniak-Kohn, Bozena
    PHARMACEUTICS, 2021, 13 (02) : 1 - 37
  • [35] Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
    Battaglia, Luigi
    Panciani, Pier Paolo
    Muntoni, Elisabetta
    Capucchio, Maria Teresa
    Biasibetti, Elena
    De Bonis, Pasquale
    Mioletti, Silvia
    Fontanella, Marco
    Swaminathan, Shankar
    EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (04) : 369 - 378
  • [36] The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease
    Cherait, Asma
    Banks, William A.
    Vaudry, David
    PHARMACEUTICS, 2023, 15 (08)
  • [37] Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development
    Bonaccorso, Angela
    Gigliobianco, Maria Rosa
    Lombardo, Rosamaria
    Pellitteri, Rosalia
    Di Martino, Piera
    Mancuso, Antonia
    Musumeci, Teresa
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2023, 28 (02) : 248 - 263
  • [38] Application of ionic liquid to enhance the nose-to-brain delivery of etodolac
    Tanigawa, Hiroaki
    Suzuki, Naoto
    Suzuki, Toyofumi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 178
  • [39] NOSE-TO-BRAIN DRUG DELIVERY OF NANOFORMULATIONS: PREPARATION AND IN VITRO EVALUATION
    Celikkol, Isik
    Esim, Ozge
    Hascicek, Canan
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27
  • [40] Nose-to-brain delivery of levetiracetam after intranasal administration to mice
    Goncalves, Joana
    Bicker, Joana
    Gouveia, Filipa
    Liberal, Joana
    Oliveira, Rui Gaetano
    Alves, Gilberto
    Falcao, Amilcar
    Fortuna, Ana
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 564 : 329 - 339
12345